Cardiometabolic Effects of Endocrine Treatment of Estrogen Receptor–Positive Early Breast Cancer

Estrogen receptor–positive early breast cancer is common and has a relatively good prognosis. It shares risk factors with cardiovascular disease, and cardiovascular disease is an important competing cause of mortality. Adjuvant endocrine therapy with aromatase inhibitors (requiring concomitant ovari...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheung, Yee-Ming, Ramchand, Sabashini K, Yeo, Belinda, Grossmann, Mathis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595530/
https://www.ncbi.nlm.nih.gov/pubmed/31259291
http://dx.doi.org/10.1210/js.2019-00096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595530/
https://www.ncbi.nlm.nih.gov/pubmed/31259291
http://dx.doi.org/10.1210/js.2019-00096

Ejemplares similares